country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-N19799

Copy Link Print Information

Diorcinol D

Diorcinol D is a natural product with antifungal activity. Diorcinol D inhibits CYP51 expression, reduces Cdr1 expression, blocks efflux pump activity, and impedes ergosterol biosynthesis. It inhibits planktonic and biofilm growth of Candida albicans. Diorcinol D is applicable to research related to fungal infections.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 1464778-45-7
Formel: C₁₉H₂₂O₃
Molecular Weight:298.38

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

Diorcinol D Chemical Structure

CAS. Nr.: 1464778-45-7

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- In Vitro
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

In Vitro

Diorcinol D inhibits planktonic growth of wild-type, Fluconazole (HY-B0101)-sensitive, Fluconazole-resistant and efflux pump-mutant Candida albicans strains, with an MIC range of 6 μg/mL to 16 μg/mL. Notably, the CDR1-deficient mutant shows increased sensitivity (MIC = 6 μg/mL)^[1].
Diorcinol D (24 h) inhibits the growth of mature biofilms formed by wild-type, fluconazole-sensitive and fluconazole-resistant Candida albicans strains, with an MIC of 32 μg/mL^[1].
Diorcinol D (8-32 μg/mL; 48 h) significantly increases cell death in mature Candida albicans YEM30 biofilms at the concentration of 32 μg/mL^[1].
Diorcinol D (4-12 μg/mL; 30 min) dose-dependently inhibits ATP-driven Rh123 efflux in both fluconazole-sensitive Candida albicans strain 18B and fluconazole-resistant strain 28I^[1].
Diorcinol D (4-12 μg/mL; 3 h) reduces the expression of CDR1 in Candida albicans CASA1 in a dose-dependent manner^[1].
Diorcinol D (4-12 μg/mL; 3 h) dose-dependently reduces ergosterol biosynthesis in Fluconazole-susceptible Candida albicans strain 18B and Fluconazole-resistant strain 28I, with a reduction range of 6.1% to 37.2%^[1].
Diorcinol D (8 μg/mL; 3 h) reduces the CYP51 gene expression level by 2.8-fold in Fluconazole-susceptible Candida albicans strain 18B, and by 1.8-fold in Fluconazole-resistant Candida albicans strain 28I^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Immunofluorescence^[1]

Cell Line:

Candida albicans CASA1
Concentration:

4, 8, and 12 μg/mL
Incubation Time:

3 h
Result:

Significant decreaseD in GFP fluorescence.

Chemical Information

CAS. Nr. 1464778-45-7
Molecular Weight 298.38
Formel C₁₉H₂₂O₃
SMILES

CC1=CC(OC2=CC(O)=CC(C)=C2C/C=C(C)/C)=CC(O)=C1
Structure Classification
- Phenols
- Polyphenols
Initial Source
- Microorganisms
endophytic fungus
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Handling Instructions (2659 KB)

Verweise

[1]. Li Y, et al. Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans. FEMS Yeast Res. 2015;15(2):fov001. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

100 mg

Angebot einholen Auf Lager